Mutagenicity of furan in female Big Blue B6C3F1 mice

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 770, Issue , 2014, Pages 46-54

  Terrell, Ashley N ^a   Huynh, Mailee ^a   Grill, Alex E ^a   Kovi, Ramesh C ^a   O'Sullivan, M Gerard ^a   Guttenplan, Joseph B ^b   Ho, Yen Yi ^c   Peterson, Lisa A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aberrant mitosis; Big Blue mouse; Furan; In vivo mutagenesis

Indexed keywords

CHEMICAL COMPOUND; CIS 2 BUTENE 1,4 DIAL; FURAN; UNCLASSIFIED DRUG; ALANINE AMINOTRANSFERASE; CARCINOGEN; FURAN DERIVATIVE; MUTAGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPERPLASIA; CELL PROLIFERATION; CHRONIC TOXICITY; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FIBROBLAST; GENE MUTATION; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LEUKOCYTE; LIVER CELL; LIVER NECROSIS; METABOLITE; MOUSE; MUTAGENIC ACTIVITY; MUTAGENICITY; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DISEASE MODEL; DNA DAMAGE; DRUG EFFECTS; FEMALE; INBRED MOUSE STRAIN; LIVER; METABOLISM; MITOSIS; MUTAGEN TESTING; MUTATION; PATHOLOGY; TOXICITY; TRANSGENE; TRANSGENIC MOUSE;

ALANINE TRANSAMINASE; ANIMALS; CARCINOGENS; DISEASE MODELS, ANIMAL; DNA DAMAGE; FEMALE; FURANS; LIVER; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MITOSIS; MUTAGENICITY TESTS; MUTAGENS; MUTATION; TRANSGENES;

EID: 84902506446     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2014.04.024     Document Type: Article

References (55)

1. International Agency for Research on Cancer Furan, Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals 1995, 393. IARC, Lyon, France.
2. National Toxicology Program Toxicology and Carcinogenesis Studies of Furan in F344/N Rats and B6C3F1 Mice 1993, US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
3. National Toxicology Program 12th Report on Carcinogens 2011, US Department of Health and Human Services, Washington DC.
4. 14C]furan in the male F344 rat. J. Toxicol. Environ. Health 1991, 34:245-257.
5. Parmar D., Burka L.T. Studies on the interaction of furan with hepatic cytochrome P-450. J. Biochem. Toxicol. 1993, 8:1-9.
6. Carfagna M.A., Held S.D., Kedderis G.L. Furan-induced cytolethality in isolated rat hepatocytes: correspondence with in vivo dosimetry. Toxicol. Appl. Pharmacol. 1993, 123:265-273.
7. Kedderis G.L., Carfagna M.A., Held S.D., Batra R., Murphy J.E., Gargas M.L. Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. Toxicol. Appl. Pharmacol. 1993, 123:274-282.
8. Mugford C.A., Carfagna M.A., Kedderis G.L. Furan-mediated uncoupling of hepatic oxidative phosphorylation in Fischer-344 rats: an early event in cell death. Toxicol. Appl. Pharmacol. 1997, 144:1-11.
9. Chen L.J., Hecht S.S., Peterson L.A. Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem. Res. Toxicol. 1997, 10:866-874.
10. Byrns M.C., Predecki D.P., Peterson L.A. Characterization of nucleoside adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem. Res. Toxicol. 2002, 15:373-379.
11. 2-etheno-2'-deoxyguanosine adducts by cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem. Res. Toxicol. 2004, 17:1607-1613.
12. Peterson L.A., Cummings M.E., Vu C.C., Matter B.A. Glutathione trapping to measure microsomal oxidation of furan to cis-2-butene-1,4-dial. Drug Metab. Dispos. 2005, 33:1453-1458.
13. Kellert M., Brink A., Richter I., Schlatter J., Lutz W.K. Tests for genotoxicity and mutagenicity of furan and its metabolite cis-2-butene-1,4-dial in L5178Y tk+/- mouse lymphoma cells. Mutat. Res. 2008, 657:127-132.
14. Marinari U.M., Ferro M., Sciaba L., Finollo R., Bassi A.M., Brambilla G. DNA-damaging activity of biotic and xenobiotic aldehydes in chinese hamster ovary cells. Cell Biochem. Funct. 1984, 2:243-248.
15. Byrns M.C., Vu C.C., Neidigh J.W., Abad J.L., Jones R.A., Peterson L.A. Detection of DNA adducts derived from the reactive metabolite of furan, cis-2-butene-1,4-dial. Chem. Res. Toxicol. 2006, 19:414-420.
16. Peterson L.A., Naruko K.C., Predecki D. A reactive metabolite of furan, cis-2-butene-1,4-dial, is mutagenic in the Ames assay. Chem. Res. Toxicol. 2000, 13:531-534.
17. Wilson D.M., Goldsworthy T.L., Popp J.A., Butterworth B.E. Evaluation of genotoxicity, pathological lesions, and cell proliferation in livers of rats and mice treated with furan. Environ. Mol. Mutagen. 1992, 19:209-222.
18. Fransson-Steen R., Goldsworthy T.L., Kedderis G.L., Maronpot R.R. Furan-induced liver cell proliferation and apoptosis in female B6C3F1 mice. Toxicology 1997, 118:195-204.
19. Moser G.J., Foley J., Burnett M., Goldsworthy T.L., Maronpot R. Furan-induced dose-response relationships for liver cytotoxicity, cell proliferation, and tumorigenicity (furan-induced liver tumorigenicity). Exp. Toxicol. Pathol. 2009, 61:101-111.
20. Cordelli E., Leopardi P., Villani P., Marcon F., Macri C., Caiola S., Siniscalchi E., Conti L., Eleuteri P., Malchiodi-Albedi F., Crebelli R. Toxic and genotoxic effects of oral administration of furan in mouse liver. Mutagenesis 2010, 25:305-314.
21. Hickling K.C., Hitchcock J.M., Chipman J.K., Hammond T.G., Evans J.G. Induction and progression of cholangiofibrosis in rat liver injured by oral administration of furan. Toxicol. Pathol. 2010, 38:213-229.
22. Hickling K.C., Hitchcock J.M., Oreffo V., Mally A., Hammond T.G., Evans J.G., Chipman J.K. Evidence of oxidative stress and associated DNA damage, increased proliferative drive, and altered gene expression in rat liver produced by the cholangiocarcinogenic agent furan. Toxicol. Pathol. 2010, 38:230-243.
23. Mortelmans K., Haworth S., Lawlor T., Speck W., Tainer B., Zeiger E. Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ. Mutagen. 1986, 7(suppl. l):1-119.
24. Glatt H., Schneider H., Liu Y. V79-hCYP2E1-hSULT1A1, a cell line for the sensitive detection of genotoxic effects induced by carbohydrate pyrolysis products and other food-borne chemicals. Mutat. Res. 2005, 580:41-52.
25. Durling L.J., Svensson K., Abramsson-Zetterberg L. Furan is not genotoxic in the micronucleus assay in vivo or in vitro. Toxicol. Lett. 2007, 169:43-50.
26. Leopardi P., Cordelli E., Villani P., Cremona T.P., Conti L., De Luca G., Crebelli R. Assessment of in vivo genotoxicity of the rodent carcinogen furan: evaluation of DNA damage and induction of micronuclei in mouse splenocytes. Mutagenesis 2010, 25:57-62.
27. Reynolds S.H., Stowers S.J., Patterson R.M., Maronpot R.R., Aaronson S.A., Anderson M.W. Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science 1987, 237:1309-1316.
28. Johansson E., Reynolds S., Anderson M., Maronpot R. Frequency of Ha-ras-1 gene mutations inversely correlated with furan dose in mouse liver tumors. Mol. Carcinog. 1997, 18:199-205.
29. Heddle J.A., Dean S., Nohmi T., Boerrigter M., Casciano D., Douglas G.R., Glickman B.W., Gorelick N.J., Mirsalis J.C., Martus H.J., Skopek T.R., Thybaud V., Tindall K.R., Yajima N. In vivo transgenic mutation assays. Environ. Mol. Mutagen 2000, 35:253-259.
30. Dean S.W., Brooks T.M., Burlinson B., Mirsalis J., Myhr B., Recio L., Thybaud V. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens. Mutagenesis 1999, 14:141-151.
31. Singh V.K., Ganesh L., Cunningham M.L., Shane B.S. Comparison of the mutant frequencies and mutation spectra of three non-genotoxic carcinogens, oxazepam, phenobarbital, and Wyeth 14,643, at the lambda cII locus in Big Blue transgenic mice. Biochem. Pharmacol. 2001, 62:685-692.
32. Hohn B. In vitro packaging of lambda and cosmid DNA. Methods Enzymol. 1979, 68:299-309.
33. 1 mice. Mol. Carcinog. 1994, 9:24-32.
34. Haseman J.K., Hailey J.R., Morris R.W. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol. Pathol. 1998, 26:428-441.
35. Shane B.S., Smith-Dunn D.L., de Boer J.G., Glickman B.W., Cunningham M.L. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice. Mutat. Res. 2000, 452:197-210.
36. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9:671-675.
37. Sobol R.W., Watson D.E., Nakamura J., Yakes F.M., Hou E., Horton J.K., Ladapo J., Van Houten B., Swenberg J.A., Tindall K.R., Samson L.D., Wilson S.H. Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:6860-6865.
38. Davies R., Gant T.W., Smith L.L., Styles J.A. Tamoxifen induces G:C->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene. Carcinogenesis 1999, 20:1351-1356.
39. Adams W.T., Skopek T.R. Statistical test for the comparison of samples from mutational spectra. J. Mol. Biol. 1987, 194:391-396.
40. Wong E., Yang K., Kuraguchi M., Werling U., Avdievich E., Fan K., Fazzari M., Jin B., Brown A.M., Lipkin M., Edelmann W. Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:14937-14942.
41. Dunson D.B., Tindall K.R. Bayesian analysis of mutational spectra. Genetics 2000, 156:1411-1418.
42. Zeger S.L., Liang K.Y., Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988, 44:1049-1060.
43. Sandercock L.E., Hahn J.N., Li L., Luchman H.A., Giesbrecht J.L., Peterson L.A., Jirik F.R. Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 2008, 29:866-874.
44. Gill S., Kavanagh M., Barker M., Weld M., Vavasour E., Hou Y., Cooke G.M. Subchronic oral toxicity study of furan in B6C3F1 mice. Toxicol. Pathol. 2011, 39:787-794.
45. Jackson A.F., Williams A., Recio L., Waters M.D., Lambert I.B., Yauk C.L. Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan. Toxicol. Appl. Pharmacol. 2014, 274:63-77.
46. Ding W., Petibone D.M., Latendresse J.R., Pearce M.G., Muskhelishvili L., White G.A., Chang C.W., Mittelstaedt R.A., Shaddock J.G., McDaniel L.P., Doerge D.R., Morris S.M., Bishop M.E., Manjanatha M.G., Aidoo A., Heflich R.H. In vivo genotoxicity of furan in F344 rats at cancer bioassay doses. Toxicol. Appl. Pharmacol. 2012, 261:164-171.
47. Wallace S.S. Biological consequences of free radical-damaged DNA bases. Free Radic. Biol. Med. 2002, 33:1-14.
48. Besaratinia A., Synold T.W., Xi B., Pfeifer G.P. G-to-T transversions and small tandem base deletions are the hallmark of mutations induced by ultraviolet a radiation in mammalian cells. Biochemistry 2004, 43:8169-8177.
49. Touati E., Michel V., Thiberge J.M., Wuscher N., Huerre M., Labigne A. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 2003, 124:1408-1419.
50. Banda M., Recio L., Parsons B.L. ACB-PCR measurement of spontaneous and furan-induced H-ras codon 61 CAA to CTA and CAA to AAA mutation in B6C3F1 mouse liver. Environ. Mol. Mutagen. 2013, 54:659-667.
51. McDaniel L.P., Ding W., Dobrovolsky V.N., Shaddock J.G., Mittelstaedt R.A., Doerge D.R., Heflich R.H. Genotoxicity of furan in Big Blue rats. Mutat. Res. 2012, 742:72-78.
52. Lambert I.B., Singer T.M., Boucher S.E., Douglas G.R. Detailed review of transgenic rodent mutation assays. Mutat. Res. 2005, 590:1-280.
53. Scarpelli D.G., Von Haam E. A study of mitosis in cervical epithelium during experimental inflammation and carcinogenesis. Cancer Res. 1957, 17:880-884.
54. Van Leeuwen A.M., Pieters W.J., Hollema H., Burger M.P. Atypical mitotic figures and the mitotic index in cervical intraepithelial neoplasia. Virchows Arch. 1995, 427:139-144.
55. Schvartzman J.M., Sotillo R., Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat. Rev. Cancer 2010, 10:102-115.